Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2014; 20(8): 2042-2050
Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.2042
Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.2042
Figure 1 Molecular targeting agents for different signaling pathways in gastric cancer.
PI3K: Phosphatidylinositol 3-kinase; HER: Human epidermal growth factor receptor; FGFR: Fibroblast growth factor (FGF) receptor; mTOR: Mammalian target of rapamycin; HGF: Hepatocyte growth factor; VEGFR: Vascular endothelial growth factor (VEGF) receptor; EGF: Epidermal growth factor; MAPK: Mitogen-activated protein kinase.
- Citation: Lim SM, Lim JY, Cho JY. Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome. World J Gastroenterol 2014; 20(8): 2042-2050
- URL: https://www.wjgnet.com/1007-9327/full/v20/i8/2042.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i8.2042